Augmedix Inc
General ticker "AUGX" information:
- Sector: Health Care
- Industry: Health Care Technology
- Capitalization: $124.4M
Augmedix Inc does not follow the US Stock Market performance with the rate: -35.8%.
Estimated limits based on current volatility of 0.2%: low 2.34$, high 2.35$
Factors to consider:
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [3.75$, 11.14$]
- 2024-12-30 to 2025-12-30 estimated range: [3.14$, 9.69$]
Financial Metrics affecting the AUGX estimates:
- Negative: Operating Income to Revenue ratio of -0.30 <= 0.01
- Negative: Non-GAAP EPS of -0.45 <= 0.11
- Negative: negative Net Income
- Negative: Operating Cash Flow per share of -0.35 <= 0.22
Short-term AUGX quotes
Long-term AUGX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $22.16MM | $30.93MM | $44.85MM |
| Operating Expenses | $39.72MM | $53.30MM | $63.63MM |
| Operating Income | $-17.55MM | $-22.37MM | $-18.78MM |
| Non-Operating Income | $0.13MM | $-1.97MM | $-0.25MM |
| Interest Expense | $2.50MM | $2.08MM | $2.25MM |
| R&D Expense | $6.68MM | $10.15MM | $11.18MM |
| Income(Loss) | $-17.42MM | $-24.34MM | $-19.03MM |
| Taxes | $0.05MM | $0.11MM | $0.14MM |
| Profit(Loss) | $-17.46MM | $-24.45MM | $-19.17MM |
| Stockholders Equity | $24.07MM | $1.47MM | $23.32MM |
| Assets | $52.07MM | $33.64MM | $66.71MM |
| Operating Cash Flow | $-18.59MM | $-16.77MM | $-15.44MM |
| Investing Cash Flow | $-0.61MM | $-1.41MM | $-3.10MM |
| Financing Cash Flow | $37.83MM | $-1.24MM | $43.37MM |
| Earnings Per Share* | $-0.59 | $-0.71 | $-0.44 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.